The noncovalent channel structure optimized the distribution and pharmaceutical properties of RG in tumor tissue, which regulated the VEGF/VEGFR axis by blocking tyrosine kinase with immunoglobulin. The gene discussed is VEGFA; the disease is neoplasm.